Nonalcoholic fatty liver disease (NAFLD) is caused by hepatic steatosis (lipid accumulation), affects up to 29 million adults in the U.S. and will become the leading cause of liver disease worldwide by 2020. There are few effective ways to prevent or treat NAFLD. A better understanding of NAFLD etiology is needed to improve its diagnosis and treatment. We previously determined that NAFLD is heritable (genetically influenced) and identified common (minor allele frequency (MAF) >5%) single nucleotide polymorphisms (SNPs) at 5 loci that associate with hepatic steatosis, first in ~7,000 individuals of European ancestry and then across ancestries. Variants at the 5 loci explain ~20% of heritability, suggesting the existence of more influential causal variants. We now aim to identify 1. causal genetic variants 2. gene(s) they work through to exert their effects, and 3. mechanism(s) by which they lead to disease. We tripled the sample size and ancestral diversity of our discovery sample, thus improving our ability to identify and fine-map causal variants. We will impute genome- wide genotypes to new denser and ancestrally diverse imputation panels, increasing our ability to identify causal common and now low-frequency (MAF 1-5%) variants across ancestries. We will use new analytical methods to perform not only single variant but also conditional and gene-based analyses across ancestries allowing us to efficiently identify causal single variants and genes. We will use new variant and gene annotations algorithms to prioritize variants and genes for functional follow up. Using this approach we identify new putative causal NAFLD variants and genes missed by previous analyses. Finally, we developed a human cell line model of NAFLD that we use to show that altering the function of three genes prioritized by the above approaches results in increased liver triglyceride accumulation, suggesting this as a common mechanism by which these genes cause NAFLD. We hypothesize that causal NAFLD-promoting human genetic variants have effects across ancestries and exert their effects in a cell-autonomous manner in hepatocytes to increase triglyceride accumulation. To test this hypothesis, we will harmonize the computed tomography hepatic steatosis phenotype and genotypes from 10 discovery cohorts (n>21K), impute genotypes to the 1000 Genomes cosmopolitan reference panel, and perform single variant, gene-based, and conditional meta- analyses across groups to identify, fine-map, and annotate putative causal variants and genes. We will follow- up top associating variants in >4,000 histologically confirmed NAFLD cases and ~3,000 controls to replicate our findings. We will knockdown and overexpress putative causal genes (wild-type and variant) in human liver cell lines and determine their effect on triglyceride accumulation and genetic mechanism of action. We will begin with three genes prioritized from our previous NAFLD meta-analysis and proceed to new genes identified from the 1000 Genomes meta-analysis. This work will help define the genetic and metabolic mechanisms that cause NAFLD and inform development of new biomarkers as well as potential therapeutics for this condition.

Public Health Relevance

Nonalcoholic fatty liver disease (NAFLD) is caused by hepatic steatosis (lipid accumulation), affects up to 29 million adults in the U.S. and will become the leading cause of liver disease worldwide by 2020; ways to prevent or treat NAFLD are lacking due to poor understanding of its pathophysiology. We propose to use new resources and methods to identify causal genetic NAFLD-associating variants in the population and to characterize their genetic and metabolic effects in a cell model of hepatic steatosis. Results from our work will help define the etiology of NAFLD and inform development of potential therapeutics for this condition.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK107904-01
Application #
9009526
Study Section
Special Emphasis Panel (ZRG1-PSE-K (02))
Program Officer
Karp, Robert W
Project Start
2016-09-10
Project End
2021-08-31
Budget Start
2016-09-10
Budget End
2017-08-31
Support Year
1
Fiscal Year
2016
Total Cost
$775,142
Indirect Cost
$261,273
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Speliotes, Elizabeth K (2018) Thwart your destiny; effect of nonacoholic fatty liver disease genes on steatosis, liver injury and cirrhosis varies by body mass index. Hepatology 68:372-374
Maguire, Lillias H; Handelman, Samuel K; Du, Xiaomeng et al. (2018) Genome-wide association analyses identify 39 new susceptibility loci for diverticular disease. Nat Genet 50:1359-1365
Weinstein, Galit; Zelber-Sagi, Shira; Preis, Sarah R et al. (2018) Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study. JAMA Neurol 75:97-104
Teslovich, Tanya M; Kim, Daniel Seung; Yin, Xianyong et al. (2018) Identification of seven novel loci associated with amino acid levels using single-variant and gene-based tests in 8545 Finnish men from the METSIM study. Hum Mol Genet 27:1664-1674
VanWagner, Lisa B; Khan, Sadiya S; Ning, Hongyan et al. (2018) Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study. Liver Int 38:706-714
Gao, Chuan; Langefeld, Carl D; Ziegler, Julie T et al. (2018) Genome-Wide Study of Subcutaneous and Visceral Adipose Tissue Reveals Novel Sex-Specific Adiposity Loci in Mexican Americans. Obesity (Silver Spring) 26:202-212
Turcot, Valérie (see original citation for additional authors) (2018) Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet 50:26-41
Liu, Dajiang J (see original citation for additional authors) (2017) Exome-wide association study of plasma lipids in >300,000 individuals. Nat Genet 49:1758-1766
Fall, Tove; Mendelson, Michael; Speliotes, Elizabeth K (2017) Recent Advances in Human Genetics and Epigenetics of Adiposity: Pathway to Precision Medicine? Gastroenterology 152:1695-1706
Marouli, Eirini (see original citation for additional authors) (2017) Rare and low-frequency coding variants alter human adult height. Nature 542:186-190

Showing the most recent 10 out of 15 publications